Partners
SciClone
SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development of therapeutics to treat life-threatening diseases.
SciClone’s lead product ZADAXIN is currently being evaluated in late-stage clinical trials for the treatment of hepatocellular carcinoma, malignant melanoma and hepatitis C. ZADAXIN is approved for sale in select markets internationally, most notably in China where SciClone has an established sales and marketing operation with over 120 members.
A key part of SciClone’s strategy is to leverage its advantage in China by in-licensing and detailing other products, such as the DC Bead, to broaden its portfolio in this rapidly gorwing pharmaceutical market.
SciClone Pharmaceuticals International Ltd. (SPIL), is the interntional sales arm of SciClone Pharmaceutical, Inc. SPIL generated nearly $27.8 million in ZADAXIN® sales in 2005. SPIL is headquartered in Hong Kong, with regional offices in Beijing, Shanghai, Siingapore and Grand Cayman, B.W.I.
SPIL has obtained regulatory approvals for ZADAXIN in various countries for the treatment of hepatitis B, hepatitis C, cancer, and for the use as a vaccine adjuvant. ZADAXIN is now approved for sale in over 30 countries worldwide including China, the Pacific Rim, the Middle East, Latin America, Eastern Europe and Italy.
Hong Kong Headquarters
Hans Schmid
Managing Director, SPIL
SciClone Pharmaceuticals Intl Ltd..
Room 3401A, Windsor House
311 Gloucester Road
Causeway Bay
Hong Kong
hschmid@spil.org
Hilda Ng
Office Manager
SciClone Pharmaceuticals Intl Ltd.
Room 3401A, Windsor House
311 Gloucester Road
Causeway Bay
Hong Kong
Phone 852-2510-0118
Fax 852-2508-1500
hng@spil.org
Shanghai
SciClone Pharmaceuticals Intl Ltd.
Room 2101-03
Shanghai Times Square
93 Huai Hai Zhong Road
Shanghai 200021
China
Phone 86-21-63910909
Fax 86-21-63918090
shanghai@spil.org
Beijing
SciClone Pharmaceuticals Intl Ltd.
Room 3102, Office Tower A
Fortune Plaza
No. 7 Dong Sanhuan Zhong Lu
Chao Yang District
Beijing 100020
China
Phone 8610-6530-9016
Fax 8610-6530-9020
beijing@spil.org